Moleculin Biotech financial statements
멀레큘린 바이오테크NASDAQ:MBRX · Nasdaq · Healthcare$0.4766-2.10%
2026-10-05 closeMoleculin Biotech's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$28M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy